Whetton AD - Search Results

1

Phosphorylation of the leukemic oncoprotein EVI1 on serine 196 modulates DNA binding, transcriptional repression and transforming ability.

White DJ, Unwin RD, Bindels E, Pierce A, Teng HY, Muter J, Greystoke B, Somerville TD, Griffiths J, Lovell S, Somervaille TC, Delwel R, Whetton AD, Meyer S. White DJ, et al. Among authors: whetton ad. PLoS One. 2013 Jun 12;8(6):e66510. doi: 10.1371/journal.pone.0066510. Print 2013. PLoS One. 2013. PMID: 23776681 Free PMC article.

2

Haemopoietic growth factors and leukaemogenesis.

Pierce A, Whetton AD. Pierce A, et al. Among authors: whetton ad. Biochem Soc Trans. 1997 May;25(2):366-70. doi: 10.1042/bst0250366. Biochem Soc Trans. 1997. PMID: 9191119 Review. No abstract available.

3

p210 Bcr-Abl expression in a primitive multipotent haematopoietic cell line models the development of chronic myeloid leukaemia.

Pierce A, Owen-Lynch PJ, Spooncer E, Dexter TM, Whetton AD. Pierce A, et al. Among authors: whetton ad. Oncogene. 1998 Aug 6;17(5):667-72. doi: 10.1038/sj.onc.1201969. Oncogene. 1998. PMID: 9704934

4

Activation of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptor subunits in a multipotential hematopoietic progenitor cell line leads to differential effects on development.

Evans CA, Pierce A, Winter SA, Spooncer E, Heyworth CM, Whetton AD. Evans CA, et al. Among authors: whetton ad. Blood. 1999 Sep 1;94(5):1504-14. Blood. 1999. PMID: 10477674 Free article.

5

Transforming growth factor-beta 1 induces apoptosis independently of p53 and selectively reduces expression of Bcl-2 in multipotent hematopoietic cells.

Francis JM, Heyworth CM, Spooncer E, Pierce A, Dexter TM, Whetton AD. Francis JM, et al. Among authors: whetton ad. J Biol Chem. 2000 Dec 15;275(50):39137-45. doi: 10.1074/jbc.M007212200. J Biol Chem. 2000. PMID: 10993901 Free article.

6

Bcr-Abl protein tyrosine kinase activity induces a loss of p53 protein that mediates a delay in myeloid differentiation.

Pierce A, Spooncer E, Wooley S, Dive C, Francis JM, Miyan J, Owen-Lynch PJ, Dexter TM, Whetton AD. Pierce A, et al. Among authors: whetton ad. Oncogene. 2000 Nov 16;19(48):5487-97. doi: 10.1038/sj.onc.1203940. Oncogene. 2000. PMID: 11114726

7

The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells.

Buckle AM, Mottram R, Pierce A, Lucas GS, Russell N, Miyan JA, Whetton AD. Buckle AM, et al. Among authors: whetton ad. Mol Med. 2000 Oct;6(10):892-902. Mol Med. 2000. PMID: 11126203 Free PMC article.

8

The specific enhancement of interferon alpha induced growth inhibition by BCR/ABL only occurs in multipotent cells.

Pierce A, Smith DL, Jakobsen LV, Whetton AD, Spooncer E. Pierce A, et al. Among authors: whetton ad. Hematol J. 2001;2(4):257-64. doi: 10.1038/sj.thj.6200114. Hematol J. 2001. PMID: 11920258

9

BCR-ABL alters the proliferation and differentiation response of multipotent hematopoietic cells to stem cell factor.

Pierce A, Spooncer E, Ainsworth S, Whetton AD. Pierce A, et al. Among authors: whetton ad. Oncogene. 2002 May 2;21(19):3068-75. doi: 10.1038/sj.onc.1205424. Oncogene. 2002. PMID: 12082538

10

Identification of primary structural features that define the differential actions of IL-3 and GM-CSF receptors.

Evans CA, Ariffin S, Pierce A, Whetton AD. Evans CA, et al. Among authors: whetton ad. Blood. 2002 Nov 1;100(9):3164-74. doi: 10.1182/blood-2001-12-0235. Blood. 2002. PMID: 12384414 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters